Eli Lilly Corp. buy The Goldman Sachs Group, Inc.
Start price
08.04.25
/
50%
€678.00
Target price
08.04.26
€810.30
Performance (%)
20.34%
End price
09.04.26
€815.90
Summary
This prediction ended on 09.04.26 with a price of €815.90. The prediction had a final performance of 20.34%. The_Goldman_Sachs_Gr has a follow-up prediction for Eli Lilly Corp. where he still thinks Eli Lilly Corp. is a Buy. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Eli Lilly Corp. | -7.368% | -7.368% | -6.248% |
| iShares Core DAX® | -1.499% | 7.705% | 5.243% |
| iShares Nasdaq 100 | 1.380% | 16.275% | 36.094% |
| iShares Nikkei 225® | -1.992% | 13.113% | 40.183% |
| iShares S&P 500 | 0.345% | 10.816% | 26.473% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $888.00 price target on the stock, down previously from $892.00.
Ratings data for LLY provided by MarketBeat
In the thread Trading Eli Lilly Corp.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten